Does anti-IL-33 antibody have a therapeutic effect in a murine model of allergic rhinitis?
Anti-IL-33 antibody has a therapeutic potential for experimental AR.
These data imply that the risk for travellers to acquire DF has been underestimated. Nevertheless, dengue haemorrhagic fever and dengue shock syndrome are still rare in travellers, but those with a history of dengue should be advised to protect themselves well from mosquitoes when travelling to endemic areas.